Inventor · disambiguated record
Ravi Kurukulasuriya
Also filed as: KURUKULASURIYA RAVI
17 granted patents·10 pending applications·71 citations·filing 2001–2022
90Inventor score
Top patents by PatentIndex Score
27 records- 0194US7217838B2Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeABBOTT LAB·Filed 2006·Granted May 15, 2007·26 cites·27 claims
- 0292US7435833B2Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzymeABBOTT LAB·Filed 2007·Granted Oct 14, 2008·24 cites·20 claims
- 0385US7528282B2Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeABBOTT LAB·Filed 2007·Granted May 5, 2009·7 cites·36 claims
- 0484US7737137B2Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzymeABBOTT LAB·Filed 2008·Granted Jun 15, 2010·7 cites·16 claims
- 0569US6350902B2Process for the selective N-formylation of N-hydroxylaminesABBOTT LAB·Filed 2001·Granted Feb 26, 2002·5 cites·11 claims
- 0666US9957264B2Geminally substituted cyanoethylpyrazolo pyridones as Janus kinase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted May 1, 2018·1 cites·9 claims
- 0764USRE41135EInhibitors of the 11-β-hydroxysteroid dehydrogenase type 1 enzymeABBOTT LAB·Filed 2008·Granted Feb 16, 2010·0 cites·27 claims
- 0861US8198331B2Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeBITNER R SCOTT·Filed 2009·Granted Jun 12, 2012·0 cites·10 claims
- 0960US2010152179A9Treatment of central nervous system disordersABBOTT LAB·Filed 2008·Application pending·0 cites
- 1059US2024368122A1Jak2 inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1158US9464072B2Treatment of central nervous system disordersABBVIE INC·Filed 2014·Granted Oct 11, 2016·0 cites·11 claims
- 1257US2024190855A1Cdk inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1355US2024308980A1Heteroaryl amides as lrrk2 inhibitors, pharmaceutical compositions, and uses thereofMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 1454US2025019380A1Pi3k-alpha inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1552US8940902B2Treatment of central nervous system disordersBITNER R SCOTT·Filed 2012·Granted Jan 27, 2015·0 cites·1 claims
- 1652US6441189B1Process for the preparation of matrix metalloproteinase inhibitorsABBOTT LAB·Filed 2001·Granted Aug 27, 2002·1 cites·4 claims
- 1751US8993632B2Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeBITNER R SCOTT·Filed 2012·Granted Mar 31, 2015·0 cites·18 claims
- 1850US2025154154A1Src inhibitors and uses thereofRELAY BINNEY STREET 2ND FLOOR·Filed 2021·Application pending·0 cites
- 1946US9688630B23,3′-disubstituted indolines as inhibitors of cholesterol ester transfer proteinMERCK SHARP & DOHME·Filed 2014·Granted Jun 27, 2017·0 cites·15 claims
- 2045US2015265613A1Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeABBVIE INC·Filed 2015·Application pending·0 cites
- 2143US9957265B2N-(2-cyano heterocyclyl) pyrazolo pyridones as janus kinase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted May 1, 2018·0 cites·11 claims
- 2243US2004209928A1Glucagon receptor antagonists/inverse agonistsFiled 2003·Application pending·0 cites
- 2341US9233979B2Compounds that are ERK inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Jan 12, 2016·0 cites·16 claims
- 2441US9226922B2Compounds that are ERK inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Jan 5, 2016·0 cites·15 claims
- 2539US10538497B2Compounds as indoleamine 2,3-dioxygenase inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Jan 21, 2020·0 cites·19 claims
- 2637US2002019539A1Process for the preparation of matrix metalloproteinase inhibitorsFiled 2001·Application pending·0 cites
- 2735US2001031896A1Process for the selective N-formylation of N-hydroxylaminesFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ravi Kurukulasuriya files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →